Oncternal Therapeutics, Inc.Oncternal Therapeutics, Inc.Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc.

No trades
See on Supercharts

Price target

30.670.00 0.00%
The 3 analysts offering 1 year price forecasts for ONCT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to ONCT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ONCT EPS for the last quarter is −3.11 USD despite the estimation of −3.09 USD. In the next quarter EPS is expected to reach −2.88 USD. Track more of Oncternal Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Oncternal Therapeutics, Inc. revenue is expected to reach ‪183.33 K‬ USD. Check out Oncternal Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ONCT price target is 30.67 USD with a max estimate of 39.00 USD and a min estimate of 25.00 USD. Check if this forecast comes true in a year, meanwhile watch Oncternal Therapeutics, Inc. stock price chart and keep track of the current situation with ONCT news and stock market news.